Conversely, the clearance of mtROS using MitoQ or the genetic deletion of NOX2 results in reduced IFN-γ production and inhibited Th1 differentiation, suggesting that ROS from different sources positively promotes Th1 differentiation in IBD. This evidence concerns the gene IFNG and inflammatory bowel disease.